Results 221 to 230 of about 464,004 (267)

Exploring Health-Related Quality of Life in Children With Pulmonary Hypertension. [PDF]

Pulm Circ
Wray J, Quyam S, Clisby H, Kelly V, Moledina S.   +4 more
europepmc   +1 more source

My Introduction to Pulmonary Hypertension. [PDF]

Pulm Circ
Farber HW.
europepmc   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Harnessing NLRX1: a new frontier in mitigating inflammation in pulmonary hypertension. [PDF]

Respir Res
Xiao Y, Cai Z, Bai M, Wu X, Wang W, Liu R, Luo Y.   +6 more
europepmc   +1 more source

Corrigendum to “Exercise ventilatory reserve predicts survival in adult congenital heart disease associated pulmonary arterial hypertension with Eisenmenger physiology” [Int J Cardiol Congenit Heart Dis, Volume 7, March 2022, 100331]

International Journal of Cardiology Congenital Heart Disease
Chinthaka B. Samaranayake, Ruth McNiven, Aleksander Kempny, Carl Harries, Laura C. Price, Michael Gatzoulis, Konstantinos Dimopoulos, Stephen J. Wort, Colm McCabe   +8 more
doaj   +1 more source

Alveolar and Bronchial Nitric Oxide Parameters in Pre-Capillary Pulmonary Hypertension. [PDF]

Biomedicines
Csoma B, Szűcs G, Bikov A, Rozgonyi ZD, Nagy A, Matics Z, Müller V, Karlócai K, Csósza G, Lázár Z.   +9 more
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Pulmonary hypertension and the role of MRI flow assessment: a systematic review. [PDF]

Br J Radiol
Alghamdi KS, Maiter A, Hyde GA, Alnasser T, Sharkey M, Salehi M, Garg P, Wild JM, Kiely D, Swift AJ, Alabed S.   +10 more
europepmc   +1 more source

Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction

Jia-Rong Jheng, Jacqueline T. DesJardin, Yi-Yun Chen, Joshua R. Huot, Yang Bai, Todd Cook, Lainey M. Hibbard, J. Rupp, Amanda Fisher, Yingze Zhang, Julio D. Duarte, Ankit A. Desai, Roberto F. Machado, Marc A. Simon, Yen‐Chun Lai   +14 more
openalex   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source